Laboratory Animal Replacement: Advances in Non-Animal Research Methods

The Three Rs framework (Replace, Reduce, Refine) has driven development of non-animal research methods. Replacement technologies are transforming what is possible without animal use.

Key Facts

Approximately 192 million animals are used in biomedical research globally each year, with mice comprising approximately 60%
Organ-on-a-chip technology creates microdevices containing living human cells that mimic organ function, replacing some animal tests
Human organoids — 3D miniature organ structures grown from stem cells — reproduce human biology more accurately than animal models for some research questions
Computer modeling and in silico drug screening can reduce the number of animal tests required in pharmaceutical development
The US FDA Modernization Act 2.0 (2022) removed the mandatory requirement for animal testing in drug approvals
Some replacement methods produce more accurate predictions of human drug responses than traditional animal models

Welfare Considerations

The Three Rs framework has driven significant advances in laboratory animal welfare since its articulation by Russell and Burch in 1959. Replacement technologies are now sufficiently advanced that regulatory agencies are beginning to accept them as alternatives to animal testing for some purposes. The welfare implications are enormous: every research question answered through a non-animal method spares animals the experience of laboratory housing, experimental procedures, and experimental endpoints. The scientific rationale for replacement also strengthens welfare advocacy — arguments that replacement methods are more scientifically accurate for predicting human responses make replacement both a welfare and a scientific priority. Current limitations include the complexity of systemic biological interactions that isolated organ models cannot capture, but the trajectory of progress is toward increasingly sophisticated replacement systems.

What You Can Do

Support funding for replacement technology research including organoids, organ-on-chip, and computational models
Advocate for regulatory reform that enables and encourages acceptance of validated replacement methods
Choose products from companies with documented commitment to replacement of animal testing in their R&D programs
Support organizations working on validation and regulatory acceptance of replacement technologies
Learn about the Three Rs framework and share information about replacement technology advances